IRON SUCROSE
Generic: IRON SUCROSE
Mylan Institutional LLCManufacturer
INTRAVENOUSRoute
IRON SUCROSEActive Substance
2025-08-08Original Approval
IRON SUCROSE is FDA application ANDA212559, sponsored by MYLAN LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
NAUSEA
244 reports
2
OFF LABEL USE
226 reports
3
ARTHRALGIA
219 reports
4
DRUG INEFFECTIVE
214 reports
5
RASH
208 reports
6
DYSPNOEA
204 reports
7
DIARRHOEA
201 reports
8
HYPERTENSION
177 reports
9
DRUG HYPERSENSITIVITY
175 reports
10
HEADACHE
154 reports